The Company is a Korea-based company mainly engaged in the molecular diagnostics business. The Company mainly provides deoxyribonucleic acid (DNA) chips, whole genome amplification systems, noninvasive prenatal testing chips and others. The Company was established on Jun 16, 2001. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 20, 2015.
Headquarters
1003 173 Digital-Ro, Geumcheon-Gu
Seoul; Seoul;
Postal Code: 08511
Contact Details: Purchase the Mg Med,Inc. report to view the information.
Website: http://www.mgmed.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service